Several studies have demonstrated that inhibition of RAGE signaling increases survival in a number of cancer models,18,19 with some reports of a multiple spliced and secreted variant of endogenous RAGE (esRAGE) whose levels correlated with decreased cancer risk and increased overall survival.20 The gene discussed is AGER; the disease is cancer.